These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2707888)

  • 41. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R; Wüthrich B; Marti-Wyss S; Cuhat J
    Schweiz Med Wochenschr; 1987 Oct; 117(44):1728-35. PubMed ID: 3685930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Rush hyposensitization with Hymenoptera venoms. Tolerance and results of therapy].
    Przybilla B; Ring J; Griesshammer B; Braun-Falco O
    Dtsch Med Wochenschr; 1987 Mar; 112(11):416-24. PubMed ID: 3816590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract.
    Müller U; Thurnheer U; Patrizzi R; Spiess J; Hoigné R
    Allergy; 1979 Dec; 34(6):369-78. PubMed ID: 546252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Demonstration of IgE and IgG antibodies against venoms in the blood of victims of fatal sting anaphylaxis.
    Hoffman DR; Wood CL; Hudson P
    J Allergy Clin Immunol; 1983 Feb; 71(2):193-6. PubMed ID: 6822695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Allergy to insect stings. diagnosis and therapy (author's transl)].
    Urbanek R
    Monatsschr Kinderheilkd (1902); 1980 Jan; 128(1):16-20. PubMed ID: 7360118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of IgG subclass antibodies in patients allergic to wasp or bee venom.
    Wilson AB; Deighton J; Lachmann PJ; Ewan PW
    Allergy; 1994 Apr; 49(4):272-80. PubMed ID: 8037359
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Natural history of Hymenoptera venom allergy in Eastern Spain.
    Fernandez J; Soriano V; Mayorga L; Mayor M
    Clin Exp Allergy; 2005 Feb; 35(2):179-85. PubMed ID: 15725189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Immunotherapy against hymenoptera venom: report of ten patients].
    Guzmán M MA; Salinas L J; Toche P P; Marinovic M MA; Gallardo O AM
    Rev Med Chil; 2007 Dec; 135(12):1566-71. PubMed ID: 18357358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Venom immunotherapy: tolerance to a 3-day protocol of rush-immunotherapy.
    Díez Gómez ML; Quirce Gancedo S; Juliá de Páramo B
    Allergol Immunopathol (Madr); 1995; 23(6):277-84. PubMed ID: 8579006
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Time course of serum inhibitory activity for facilitated allergen-IgE binding during bee venom immunotherapy in children.
    Varga EM; Francis JN; Zach MS; Klunker S; Aberer W; Durham SR
    Clin Exp Allergy; 2009 Sep; 39(9):1353-7. PubMed ID: 19538349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The value of immunotherapy with venom in children with allergy to insect stings.
    Valentine MD; Schuberth KC; Kagey-Sobotka A; Graft DF; Kwiterovich KA; Szklo M; Lichtenstein LM
    N Engl J Med; 1990 Dec; 323(23):1601-3. PubMed ID: 2098016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insect venom allergy: diagnosis and treatment.
    Valentine MD
    J Allergy Clin Immunol; 1984 Mar; 73(3):299-304. PubMed ID: 6366028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prospective observations on stopping prolonged venom immunotherapy.
    Golden DB; Addison BI; Gadde J; Kagey-Sobotka A; Valentine MD; Lichtenstein LM
    J Allergy Clin Immunol; 1989 Aug; 84(2):162-7. PubMed ID: 2760358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J; Golden DBK
    Ann Allergy Asthma Immunol; 2018 Sep; 121(3):276-277. PubMed ID: 29909053
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy for hymenoptera venom and biting insect hypersensitivity.
    Müller UR; Golden DB; Demarco PJ; Lockey RF
    Clin Allergy Immunol; 2004; 18():541-59. PubMed ID: 15042934
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunotherapy in bee-sting anaphylaxis. Use of honeybee venom.
    Busse WW; Reed CE; Lichtenstein LM; Reisman RE
    JAMA; 1975 Mar; 231(11):1154-6. PubMed ID: 1172815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk assessment of Hymenoptera re-sting frequency: implications for decision-making in venom immunotherapy.
    von Moos S; Graf N; Johansen P; Müllner G; Kündig TM; Senti G
    Int Arch Allergy Immunol; 2013; 160(1):86-92. PubMed ID: 22948338
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The evaluation of the common diagnostic methods of hypersensitivity for bee and yellow jacket venom by means of an in-hospital insect sting.
    Blaauw PJ; Smithuis LO
    J Allergy Clin Immunol; 1985 May; 75(5):556-62. PubMed ID: 3989140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.